Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 14, 2016
Patent Application Number
13830712
Date Filed
March 14, 2013
Patent Primary Examiner
Patent abstract
Provided herein are 3,5-diaminopyrazoles, for example, compounds of Formula IA, that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
